Dr. Feng Ding PhD
Wenzhou Medical University (WMU) · china
Editorial leadership for Journal of Biotechnology and Biomedical Science ISSN 2576-6694
Research interests
- Multidrug Resistance (Mdr)
- Efflux Transporters Bacterial Pathogenesis (Mycobacterium Tuberculosis) Nanobiochemistry
- Nanosensors Fluorescence Spectroscopy
- Super-Resolution Imaging Antimicrobial Therapies
- Drug Carriers
Biography
Dr. Feng Ding is a Research Associate Professor specializing in Microbiology, Immunology, and Nanobiochemistry. His research focuses on the molecular mechanisms and development of countermeasures against multidrug resistance (MDR), particularly in pathogens like Mycobacterium tuberculosis. Dr. Ding utilizes advanced nanoparticle-based probes and sensors for super-resolution, real-time imaging of host-bacteria interactions and MDR transporters. His work is dedicated to developing novel, cost-effective therapeutic strategies and nanocarriers to combat infectious diseases and enhance drug efficacy.
Education Details
- Ph.D. (Biomedical Science/Chemistry), Old Dominion University, USA (2008–2013)
- M.S. (Biochemistry/Molecular Biology), Second Military Medical University, China (2002–2006)
- B.S. (Biotechnology), Soochow University, China (1997–2001)
Professional Background
- Research Associate Professor (Current), School of Basic Medical Sciences, Wenzhou Medical University, China (since 2016).
- Postdoctoral Research Fellow, Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, USA (2014–2015).
- Research Associate (Malaria Vaccine Development), Second Military Medical University, China (2002–2007).
Achievements
- Pioneered the application of dark-field optical microscopy and far-field photostable optical nanoscopy using nanoparticle probes to study Multidrug Resistance (MDR) efflux functions in real-time.
- Involved in the Phase I clinical trial study of a malaria vaccine candidate.
Current Research Projects
Dr. Ding's work focuses on combating antibiotic resistance and enhancing diagnostics:
- Developing novel molecular probes and nano-assays for the accurate detection and real-time imaging of biological processes.
- Deciphering the molecular mechanisms by which M. tuberculosis intervenes with host cell processes (autophagy, apoptosis).
- Designing and testing new nanoparticle-based systems to overcome multidrug resistance in pathogens like P. aeruginosa and M. tuberculosis.
Academic Profiles of Dr. Feng Ding
Explore his academic and professional presence across trusted platforms.
Selected publications
- Reversible Chemosensor for Bioimaging and Biosensing of Zn(II) and hpH in Cells, Larval Zebrafish, and Plants with Dual-Channel Fluorescence Signals 2021 cited 45×
- A reaction-based colorimetric and ratiometric chemosensor for imaging identification of HClO in live cells, mung bean sprouts, and paper strips 2021 cited 33×
- A novel ratiometric and colorimetric chemosensor for highly sensitive, selective and ultrafast tracing of HClO in live cells, bacteria and zebrafish 2021 cited 26×
- Antibiotic Drug Nanocarriers for Probing of Multidrug ABC Membrane Transporter of Bacillus subtilis 2020 cited 16×
- Multifunctional chemosensor for tracing Ga(III), hypochlorite and pH change with bioimaging in living cells, Pseudomonas aeruginosa and Zebrafish 2021 cited 12×
- Emerging roles of the epitranscriptome in parasitic protozoan biology and pathogenesis 2024 cited 7×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JBBS for your work?
This journal is guided by Dr. Feng Ding (Wenzhou Medical University (WMU)) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.